Product Information
SUCRALFATE 1 GM/10 ML SUSP is a generic product labeled by Strides Pharma Inc., priced at $0.1174 per ML under NDC 64380014901. Its NADAC has been published 95 times since Sep 4, 2024.
Strength
1 g/10mL
Manufacturer
Strides Pharma Inc.NDC
64380014901
Classification
Generic
Dosage Form
SUSPENSION
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
SUCRALFATEApproval Type
Generic (ANDA)
FDA Application
ANDA216474On Market Since
7/10/2024
Pharmacological Classes
Price Statistics
The NADAC for SUCRALFATE 1 GM/10 ML SUSP has been published 95 times since Sep 4, 2024, and over the history we have for it it has declined 51.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1174 per ML |
|---|---|
| All-time high | $0.2598 (Oct 16, 2024) |
| All-time low | $0.1174 (Jun 17, 2026) |
| 52-week high | $0.1316 |
| 52-week low | $0.1174 |
| Median price | $0.1253 |
| Average price | $0.1626 |
| Largest weekly change | -14.7% (Feb 19, 2025) |
| Weeks tracked | 95 |
| Tracking since | Sep 4, 2024 |
Generic Alternatives
The matcher finds 6 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 6 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 3% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of SUCRALFATE 1 GM/10 ML SUSP?
The current National Average Drug Acquisition Cost (NADAC) for SUCRALFATE 1 GM/10 ML SUSP, manufactured by Strides Pharma Inc., is $0.1174 per ML (NDC 64380014901), effective Jun 24, 2026.
How has the price of SUCRALFATE 1 GM/10 ML SUSP changed over time?
Over the history we have for it, the NADAC for SUCRALFATE 1 GM/10 ML SUSP has declined 51.7%. It has been tracked across 95 weekly CMS publications since Sep 4, 2024.
What are the highest and lowest recorded NADAC prices for SUCRALFATE 1 GM/10 ML SUSP?
Since Sep 4, 2024, the NADAC for SUCRALFATE 1 GM/10 ML SUSP has ranged from a low of $0.1174 (Jun 17, 2026) to a high of $0.2598 (Oct 16, 2024), with a median of $0.1253 per ML.
Are there cheaper alternatives to SUCRALFATE 1 GM/10 ML SUSP?
Yes. 6 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, SUCRALFATE 1 GM/10 ML SUSP, is $0.1144 per ML — about 3% below SUCRALFATE 1 GM/10 ML SUSP.
Who manufactures SUCRALFATE 1 GM/10 ML SUSP?
SUCRALFATE 1 GM/10 ML SUSP (NDC 64380014901) is labeled by Strides Pharma Inc., and CMS classifies it as a generic product.